Etoposide
Product description
Etoposide or VP-16 is a cytotoxic anticancer drug which belongs to thetopoisomerase inhibitor drug class. It is used as a form of chemotherapy for cancers such as Kaposi’s sarcoma, Ewing's sarcoma, lung cancer, testicular cancer, lymphoma, nonlymphocytic leukemia, and glioblastoma multiforme. It is often given in combination with other drugs (such as bleomycin in treating testicular cancer). It is also sometimes used in a conditioning regimen prior to a bone marrow or blood stem cell transplant.
It is approved by NMPA.
It is approved by US-FDA and EDQM, and US-DMF and EDMF are available.
Stability study zone IVB data are available.
Read more
It is approved by NMPA.
It is approved by US-FDA and EDQM, and US-DMF and EDMF are available.
Stability study zone IVB data are available.
Specifications
| CAS Registry Number | 33419-42-0 |
|---|---|
| Categories | APIs (Active Pharmaceutical Ingredients) |
| Sales markets | Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America |
| Supplied from | China |
Products from other suppliers
❮
❯
-
VALSARIN 80/VALSARIN 160/VALSARIN 320
-
NURONORM
-
DERMOGEL NEW to treat inflammatory skin conditions
-
Anlitin (Levonorgestrel 1.5 mg) Tablet
-
Levocarnitine (LEKARNITIN) 1 G/5 ML SOLUTION FOR I.V. INJECTION
-
FOOD GRADE EPOXY COATING FOR INTERNAL POTABLE TANK PIPELINE - CLEAN TECH PW
-
Synatura Syrup
-
Ectoin® Allergy Eye Drops 2% - The innovation for treatment and prevention of allergic conjunctivitis symptoms
-
Kalmosan Skin Lotion
-
ComBE Five Pentavalent DTP-HepB-Hib
Are you a supplier?
Here's what CPhI Online can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation